Evidence map›Paper›PMID 37601026›Full record

ArticleResearch and practice in thrombosis and haemostasis2023

Dabigatran-reversal failure using standard dose of idarucizumab: a systematic review and meta-analysis of cases.

Sophie Melicine, Paul Billoir, Dorothée Faille, Erik Lerkevang Grove, Minh P Lê, Nadine Ajzenberg, David M Smadja, Nicolas Gendron

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Research and practice in thrombosis and haemostasis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sophie MelicineHematology Department, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, Paris, France.
Paul BilloirUnité d'hémostase vasculaire, UNIROUEN, INSERM U1096, Normandie Univ, Hôpital Universitaire Rouen, Rouen, France.
Dorothée FailleLaboratoire d'Hématologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude-Bernard, Paris, France.
Erik Lerkevang GroveDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Minh P LêUniversité Paris Cité, INSERM, UMRS 1144, Paris, France.
Nadine AjzenbergLaboratoire d'Hématologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat-Claude-Bernard, Paris, France.
David M SmadjaHematology Department, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, Paris, France.
Nicolas GendronHematology Department, Assistance Publique Hôpitaux de Paris, Centre-Université de Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37601026
PMCPMC10439387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.